Abrantes
Adrian A. Abrantes, Murrieta, CA US
Patent application number | Description | Published |
---|---|---|
20120197880 | SYSTEM, METHOD, AND LOGIC FOR OPTIMIZED GEOSPATIAL DATA DELIVERY - A method may include subscribing each of a plurality of users to receive native-format geospatial information from a data source. The method may also include receiving native-format geospatial information from the data source. The method may further include analyzing native-format geospatial information and previously-rendered geospatial data file fragments to determine whether to update one or more previously-rendered geospatial data file fragments. The method may additionally include translating native-format geospatial information into geospatial data file fragments in response to a determination to update one or more previously-rendered geospatial data file fragments, and storing such geospatial data file fragments. | 08-02-2012 |
Audrey Jill Abrantes, Calamba City PH
Patent application number | Description | Published |
---|---|---|
20090054088 | Sending time-sensitive information via a short message service - A method for informing at least one person of time-sensitive information via a short message service is disclosed. The technology initially accesses a data base of contact information related to at least one person in response to receiving a request to deliver the time-sensitive information via a short message service. The time-sensitive information is then assigned to at least one person. The time-sensitive information is then sent to at least one person. Then feedback is received as to at least one person's receipt of the time-sensitive information. | 02-26-2009 |
Christiane De Freitas Abrantes, Belo Horizonte BR
Patent application number | Description | Published |
---|---|---|
20110008391 | VACCINE COMPOSITION AND IMMUNIZATION METHOD - The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of | 01-13-2011 |
20140255448 | VACCINE COMPOSITION AND IMMUNIZATION METHOD - The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, monophosphoryl lipid A, or aluminum hydroxide plus CpG as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of | 09-11-2014 |